Cour Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer

Cour Pharmaceuticals announced the appointment of Dannielle Appelhans as Chief Operating Officer, effective immediately. In this role, Dannielle will oversee and execute the Company’s research and development, technical development, technical operations, and quality. Dannielle served most recently as the Chief Executive Officer of Rubius Therapeutics, Inc.

Cour Pharmaceuticals is a biotechnology company focused on developing novel therapies for autoimmune and inflammatory diseases.